Dermata Therapeutics, Inc. (DRMA) Insider Trading Activity

NASDAQ$0.8498
Market Cap
$4.21M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
374 of 849
Rank in Industry
219 of 491

DRMA Insider Trading Activity

DRMA Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$1,270
1
50
Sells
$13
1
50

Related Transactions

Bedoya-Toro Munera Maria ESVP, Regulatory Affairs
1
$1,270
0
$0
$1,270
Scott Kathleen D.director
0
$0
1
$13
$-13

About Dermata Therapeutics, Inc.

Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Insider Activity of Dermata Therapeutics, Inc.

Over the last 12 months, insiders at Dermata Therapeutics, Inc. have bought $1,270 and sold $13 worth of Dermata Therapeutics, Inc. stock.

On average, over the past 5 years, insiders at Dermata Therapeutics, Inc. have bought $1,270 and sold $13 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Bedoya-Toro Munera Maria E (SVP, Regulatory Affairs) — $1,270.

The last purchase of 1,000 shares for transaction amount of $1,270 was made by Bedoya-Toro Munera Maria E (SVP, Regulatory Affairs) on 2026‑02‑17.

List of Insider Buy and Sell Transactions, Dermata Therapeutics, Inc.

2026-06-16SaleScott Kathleen D.director
11
0.0016%
$1.19
$13
-0.84%
2026-02-17PurchaseBedoya-Toro Munera Maria ESVP, Regulatory Affairs
1,000
0.1479%
$1.27
$1,270
-2.38%
2021-08-16PurchasePROEHL GERALD TPresident, CEO and Chairman
152,857
0.2495%
$6.87
$1.05M
-74.91%
Total: 3
*Gray background shows transactions not older than one year

DRMA Institutional Investors: Active Positions

Increased Positions5+100%25,124+27.24%
Decreased Positions2-40%90,464-98.08%
New Positions3New20,098New
Sold Out Positions<1Sold Out81,654Sold Out
Total Postitions8+60%26,892-70.84%

DRMA Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Armistice Capital, Llc$178.008.16%81,654+49,436+153.44%2025-09-30
Ubs Group Ag$22.001.01%10,047+951+10.46%2025-09-30
Tower Research Capital Llc (Trc)$1.000.04%426-106-19.93%2025-09-30
Sbi Securities Co., Ltd.$00.01%10100%2025-09-30
Bank Of America Corp /De/$00%4+<1+33.33%2025-09-30
Citigroup Inc$00%0-6Sold Out2025-09-30
Two Sigma Securities, Llc$00%0-1,472Sold Out2025-09-30
Boothbay Fund Management, Llc$00%0-12,000Sold Out2025-09-30
Geode Capital Management, Llc$00%0-2,739Sold Out2025-09-30
Jones Financial Companies Lllp$00%0-1,200Sold Out2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.